Oxley suggested estimate next interim look sometime near the end...

Oxley suggested estimate next interim look sometime near the end of October. Indicated that mortality rate atm was 60% in comparable patient population

Apparently lots of US administration on the line - Gave a big plug for govt focusing some of their efforts on therapies rather than just vaccines (called out BARDA in particular). Was question about collaboration and turned it around to remind everyone that the first commercially approved cell therapy was approved in Japan 4 years ago due to the government fostering developing/approval. Temcell sitting at 40% market share after 3 years.

Oxley very strong on the US govt having done its job of providing funding but it is up to the agencies to step up to collaborate to enable - specifically calling out HHS, FDA CBER -

Closing comment - need to bring attention to patients and families in the US that get COVID and end up on patients - asking what we are doing for them? We have an answer for unifected (vaccines) but not for infected. Again called out BARDA. HHS, FDA to take up the spirit of collaboration to enable warp speed adoption of therapies.